Trial Profile
A phase II trial of intravenous ibandronic acid in patients with osteoporosis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Ibandronic acid (Primary)
- Indications Osteoporosis
- Focus Pharmacodynamics; Therapeutic Use
- 05 Nov 2010 New trial record.